Portfolio company
Rejuvenate Biomed NV
Belgium · £13.3m raised
Raised
£13.3m
Latest stage
Series B
Rounds recorded
1
Backed by
1 investor
Sectors
About
This clinical-stage biotechnology company develops combination therapeutics for patients with age-related diseases, focusing on muscle weakness and sarcopenia using artificial intelligence discovery platforms.
SourceFunding history · 1
Similar companies
Rejuvenate Biomed
This biotech company develops AI-enabled prescription combination drugs to treat age-related diseases and muscle decline in older patients.
Juvena Therapeutics
This biotechnology company develops protein-based regenerative medicines for patients with chronic muscle and metabolic diseases.
Rejuveron
This biotechnology firm develops medicines and regenerative therapies targeting age-related diseases to improve healthspan for the aging population.
Rejuveron Life Sciences
This clinical-stage biotechnology company develops regenerative medicines and small-molecule therapies for patients with age-related diseases to improve healthspan and longevity.
Shift Bioscience
This biotechnology company develops cellular rejuvenation therapeutics and an AI-driven discovery platform for pharmaceutical researchers to treat age-related diseases.
Rejuveron Life Sciences AG
This biotechnology company develops regenerative therapies and medicines for patients with age-related diseases and vision loss.
RejuverSen
This biotechnology firm develops senolytic therapies to eliminate senescent cells for treating cancer, fibrosis and age-related diseases in humans.
Turn Biotechnologies
This company develops mRNA medicines and delivery platforms for cellular rejuvenation and tissue repair to treat age-related conditions for patients and pharmaceutical partners.
